Bulk Orders 20+ vials
Volume pricing applies automatically from three vials and reaches 20% at twenty. Larger runs, institutional supply and custom timelines get a quote.
Ask about bulk
Bioregulator
Cartalax is a peptide research compound supplied in a 20MG lyophilized research vial, designed for controlled laboratory investigations involving cartilage pathway research, connective-tissue signaling models, extracellular matrix biology, cellular repair pathways, tissue-response systems, and...
Bundle & save
Referral program · researchers save 10%, you earn 15% backThe compounds researchers order most, by verified order volume.
More ways to save
Volume pricing applies automatically from three vials and reaches 20% at twenty. Larger runs, institutional supply and custom timelines get a quote.
Ask about bulkVerified test results
Each batch is analyzed by an independent third-party laboratory before release. The lots below were tested by Chromate and ILS Laboratories. Below is the report for lot FX35, summarized from the certificate the lab published.
Every lot we have published for this compound, grouped by the lab that tested it, newest first. Open any certificate below, exactly as the lab released it.
Side by side
Technical specifications
Important research notice
Not for human, veterinary, or food use. This product is sold exclusively for laboratory research purposes. It is not intended to diagnose, treat, cure, or prevent any disease, and has not been evaluated by the FDA.
All referenced publications and registries are sourced from peer-reviewed journals and official registries. They are provided for educational reference only and are not product claims.
By purchasing, you confirm you are a qualified researcher and will handle this product in accordance with all applicable laws and regulations.
Ready when you are
The lot on this page links to the signed certificate for that batch.
Cartalax is a peptide research compound supplied in a 20MG lyophilized research vial, designed for controlled laboratory investigations involving cartilage pathway research, connective-tissue signaling models, extracellular matrix biology, cellular repair pathways, tissue-response systems, and peptide-fragment research.
Disguised Alpha Cartalax is positioned for researchers studying tissue-specific peptide signaling and connective-tissue pathway behavior under controlled laboratory conditions.
Compound: Cartalax
Total Content: 20MG
Format: Lyophilized research vial
Research Category: Connective tissue / cartilage pathway peptide research
Research Focus: Cartilage signaling, extracellular matrix research, connective-tissue biology, peptide-fragment studies, cellular repair pathway models, and tissue-response systems.
Cartalax is studied in experimental models involving cartilage-associated peptide signaling, extracellular matrix behavior, connective-tissue response pathways, and tissue-level cellular communication.
Studied in models involving cartilage-associated signaling, connective-tissue response, and tissue-level pathway behavior.
Relevant to extracellular matrix research, tissue-support systems, structural protein environments, and cellular repair pathway studies.
Supplied as a 20MG lyophilized research vial for clear product presentation and controlled laboratory workflows.
Cartalax is studied in laboratory models involving connective-tissue signaling, cartilage-associated pathway activity, extracellular matrix biology, peptide-fragment behavior, and tissue-response systems.
Connective-tissue research is important in controlled laboratory models because cartilage and extracellular matrix environments rely on complex signaling systems that influence tissue structure, cellular communication, and matrix remodeling behavior.
The 20MG vial format provides researchers with a clean lyophilized presentation for investigations involving cartilage pathway comparison, matrix biology models, and tissue-level peptide signaling under controlled experimental conditions.
Peptide research products require careful attention to identity review, analytical documentation, vial presentation, labeling accuracy, storage expectations, and packaging quality.
Disguised Alpha reviews Cartalax as a complete research product with attention to documentation, finished-vial presentation, internal QA, and direct fulfillment accountability.
We believe researchers should be able to verify the standards we speak about. Learn more about the independent laboratories we work with below.
Visit ILS Labs Visit ChromateDisguised Alpha is built around direct accountability. Every order is processed, inspected, packaged, and shipped by our in-house team instead of being passed off to a third-party logistics warehouse.
This gives us tighter control over fulfillment accuracy, packaging quality, storage standards, and customer experience. Our goal is not to be the cheapest research supplier. It is to provide professionally handled compounds with real quality oversight behind them.
Research Use Disclaimer: This product is sold strictly for laboratory research purposes only. It is not intended for human consumption, medical use, diagnostic use, therapeutic use, joint-health use, cartilage treatment use, injury treatment use, supplement use, injection use, or the treatment, prevention, or diagnosis of any disease. Researchers are responsible for ensuring proper handling, storage, preparation, compatibility review, and compliance with all applicable regulations.Yes. Cartalax is the tripeptide Ala-Glu-Asp (AED), built from alanine, glutamic acid and aspartic acid; the formula this page lists, C₁₂H₁₉N₃O₈ at 333.29 g/mol, matches PubChem's record for that sequence. Earlier papers code it T-31, and the St Petersburg group that studies it calls it a peptide bioregulator, its own term rather than a regulatory or drug class.
No. Epitalon is the tetrapeptide Ala-Glu-Asp-Gly (AEDG); Cartalax is Ala-Glu-Asp (AED), the same first three residues without the closing glycine. Both come from the same St Petersburg short-peptide program, whose 2021 review lists them as separate peptides, and the two have been tested side by side in skin fibroblast and stem cell cultures.
Cell cultures, tissue explants, computer docking and rats. Papers from the St Petersburg group and its collaborators tested AED, often beside other short peptides, in kidney cells, skin fibroblasts, chondrocytes and stem cells, in rat kidney explants, and in rats after ovariectomy, with a jaw defect or with cisplatin-induced kidney injury, mostly reading a few markers.
Not in any study we found. A PubMed search for Cartalax, Kartalax or Kartalaks returns 8 records, 7 cell, tissue-explant or rat studies and 1 review, each with V. Kh. Khavinson or a colleague from his St Petersburg institute among its authors. The evidence is thin, we found no independent replication, and Drugs@FDA lists no Cartalax product.
Match the selected product option and assigned shipping lot to the corresponding report in the COA portal. Check the compound or components, sample identification, test date, methods and results actually reported. Results for another lot or formulation are not a substitute.
No. Analytical purity and measured content are different measurements. Compare labeled quantity with measured content only where the report provides a compatible result and unit.
Read the Cartalax research reference. For batch documentation or formulation questions, contact Disguised Alpha.
Cartalax is a peptide research compound supplied in a 20MG lyophilized research vial, designed for controlled laboratory investigations involving cartilage pathway research, connective-tissue signaling models, extracellular matrix biology, cellular repair pathways, tissue-response systems, and peptide-fragment research.
The current certificate is matched to the selected product option and assigned shipping batch.
Enable JavaScript to view the certificate for your selected option.